Accessibility Menu

Zimmer Biomet(FRA) ZIM

Market Cap€16.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+121%
5 Year+12%
1 Year-13%
1 Month+6%
€86.36
+0.72%
+0.62Today
Zimmer Biomet last closing stock price
MetricPriceDate
Last closeEUR 100.752025-03-14
Zimmer Biomet stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.34%EUR 99.422025-03-07
1 month+5.7%EUR 95.322025-02-12
3 month-0.79%EUR 101.552024-12-13
Year to date-1.18%EUR 101.952024-12-30
1 year-12.62%EUR 115.302024-03-14
3 year-5.75%EUR 106.902022-03-15
5 year+12.37%EUR 89.662020-03-13
Since inception+120.98%EUR 38.802008-10-01

Zimmer Biomet Financials at a Glance

Market Cap

€16.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€7.30K

Net Income (TTM)

€691.67

EPS (TTM)

€3.52

P/E Ratio

23.97

Dividend

€0.83

Beta (Volatility)

-0.03 (Low)

Price

€86.36

Volume

0

Open

€86.36

Previous Close

€85.74

Daily Range

€86.36 - €86.36

52-Week Range

€67.36 - €92.52

Estimated Earnings Date

N/A

ZIM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zimmer Biomet

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. The company operates through the following segments: Americas Orthopedics, EMEA, Asia Pacific, and Americas Spine and Global Dental. The Americas Orthopedics segment consists of the U.S. market and includes other North, Central, and South American markets for the firm’s orthopedic product categories. The EMEA segment focuses on Europe and includes the Middle East and African markets for all product categories except Dental. The Asia Pacific segment consists of Japan, China, and Australia and includes other Asian and Pacific markets for all product categories except Dental. The Americas Spine and Global Dental segment focuses on the U.S. market and includes other North, Central, and South American markets for the firm's spine business, and all geographic markets for its dental business. This segment is also involved in research, development engineering, medical education, and brand management. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Industry

Healthcare Equipment and Supplies

Employees

17,000

CEO

Ivan Tornos, Jr., MBA

ZIM Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

6.37%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.17%

Dividend Yield

0.98%

Payout Ratio

N/A

Stock Overview

Market Cap

€16.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

190.74M

Volume

0

Avg. Volume

12.515

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Zimmer Biomet Performance Analysis

Zimmer Biomet annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 6,603,301,23214.3%
20232023-12-31EUR 6,839,416,5993.6%
20242024-12-31EUR 7,098,701,6903.8%
20252025-12-31EUR 7,293,692,0272.7%
Zimmer Biomet annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.05-35.2%
20232023-12-31EUR 4.52331.4%
20242024-12-31EUR 4.10-9.3%
20252025-12-31EUR 3.14-23.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.87K

+1.0%

Gross Profit

€1.18K

+1.0%

Gross Margin

62.91%

+1.0%

Market Cap

€16.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.91

N/A

Employees

17,000

N/A

Net Income

€171.67

+1.3%

EBITDA

€562.48

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€6.90K

-0.4%

Total Debt

€6.54K

+1.0%

Accounts Receivable

€1.55K

+1.1%

Inventory

€1.99K

+0.9%

Long Term Debt

€5.49K

+1.0%

Short Term Debt

€1.05K

+1.5%

Return on Assets

3.51%

+0.9%

Return on Invested Capital

3.70%

+1.3%

Free Cash Flow

€266.38

+1.3%

Operating Cash Flow

€387.04

+1.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,785.76-0.00%
^DJIDJI
$53,732.41-0.00%
^IXICNASDAQ
$26,729.16-0.00%
BTCBitcoin
$63,110.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$144.95-0.00%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$40.28+0.00%
SPCXSpace Exploration Technologies
$140.00-0.01%
NOKNokia
$10.76+0.02%

Questions About ZIM

What is the current price of Zimmer Biomet?

Zimmer Biomet is trading at €86.36 per share.

What is the 52-week range for Zimmer Biomet?

Over the past 52 weeks, Zimmer Biomet has traded between €67.36 and €92.52.

How much debt does Zimmer Biomet have?

As of the most recent reporting period, Zimmer Biomet reported total debt of €6.54B.

How much cash does Zimmer Biomet have on hand?

Zimmer Biomet reported €358.61M in cash and cash equivalents in its most recent financial results.

What is Zimmer Biomet’s dividend yield?

Zimmer Biomet currently has a dividend yield of 0.98%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.